LumiraDx develops point-of-care diagnostics solutions on a portable, cloud-connected reader using finger-prick blood samples tested on disposable, microfluidic strips. The company is working to achieve lab-quality performance and health-IT integration at point-of–care settings globally. The foundation invested in the company to develop priority global health diagnostic tests on its platform, and to accelerate access to these and other tests for patients living in low income countries.
Investment Date: August 2018